ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RDHL Redhill Biopharma Ltd

0.5274
0.0002 (0.04%)
Pre Market
Last Updated: 06:42:15
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Redhill Biopharma Ltd RDHL NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.0002 0.04% 0.5274 06:42:15
Open Price Low Price High Price Close Price Previous Close
0.5272
more quote information »

Recent News

Date Time Source Heading
2/20/202415:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/20/202406:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/20/202406:00PRNUSRedHill's Opaganib Protects Against Radiation-Induced Lung..
2/16/202407:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/15/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/13/202415:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/02/202415:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/01/202409:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/26/202411:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/26/202411:46PRNUSRedHill Biopharma Announces Closing of $8 Million Registered..
1/26/202408:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/26/202408:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/25/202408:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/25/202408:05PRNUSRedHill Biopharma Announces $8 Million Registered Direct..
1/25/202405:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/25/202405:00PRNUSRedHill Announces New USPTO Patent Grant for Talicia® for H...
12/20/202307:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/20/202307:45PRNUSRedHill and U.S. Army Announce Opaganib and RHB-107..
12/12/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202306:00PRNUSRedHill Biopharma Regains Compliance with Nasdaq Minimum Bid..
12/06/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/04/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/04/202306:00PRNUSRedHill Announces New, Non-Dilutive External Funding of..
12/01/202315:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/27/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/27/202306:00PRNUSRedHill Biopharma Announces FDA Grant of 5-Year U.S. Market..
11/16/202311:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/14/202307:00PRNUSRedHill Biopharma Announces the Transfer of its Listing to..
10/26/202315:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/23/202315:06EDGAR2Form F-3/A - Registration statement by foreign private..
10/16/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/13/202307:13EDGAR2Form F-3 - Registration statement by foreign private issuers
10/10/202308:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/03/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/03/202306:00PRNUSRedHill and U.S. Army Announce Opaganib's Ebola Virus..
9/29/202307:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/22/202315:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/22/202315:15PRNUSRedHill Biopharma Announces Receipt of Nasdaq Notification..
9/18/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/18/202306:00PRNUSRedHill Announces FDA sNDA Approval for Talicia®
9/05/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/05/202306:00PRNUSRedHill Announces New USPTO Notice of Patent Allowance for..
8/17/202306:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/17/202306:00PRNUSRedHill Biopharma Provides H1/23 Financial Results and..
8/11/202315:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/09/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/08/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/04/202315:05EDGAR2Form F-3 - Registration statement by foreign private issuers
8/01/202306:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/01/202306:00PRNUSRedHill Biopharma Announces Talicia Approved in the United..

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com